| 產(chǎn)品編號(hào) | D58171 |
| 英文名稱 | Zoledronic Acid |
| 中文名稱 | 唑來膦酸 |
| 別 名 | CGP 42446; CGP42446A; ZOL 446; Zoledronate; CGP-4244; Zometa |
| 克 隆 號(hào) | |
| CAS | 118072-93-8 |
| 理論分子量 | 272.09 kDa |
| 檢測(cè)分子量 | |
| 保存條件 | Powder: -20℃ for 3 years | In solvent: -80℃ for 1 year |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產(chǎn)品介紹 |
Zoledronate is a bisphosphonate. Zometa is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer. It can also be used to treat hypercalcemia of malignancy and can be helpful for treating pain from bone metastases. An annual dose of Zoledronate may also prevent recurring fractures in patients with a previous hip fracture. Zoledronate is a single 5 mg infusion for the treatment of Paget's disease of bone. In 2007, the FDA also approved Reclast for the treatment of postmenopausal osteoporosis. |
